规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | ZLDI-8 acts as an inhibitor of the Notch activating/cleaving enzyme ADAM-17, preventing Notch protein cleavage. It reduces the levels of proteins associated with survival, anti-apoptosis, and epithelial-mesenchymal transition (EMT). Furthermore, ZLDI-8 serves as a competitive and irreversible inhibitor of tyrosine phosphatase (Lyp), exhibiting an IC50 of 31.6 μM and a Ki of 26.22 μM. It effectively curbs the proliferation of MHCC97-H cells with an IC50 of 5.32 μM[1][2]. |
Animal study | ZLDI-8 treatment (0.2-2 mg/kg; intraperitoneal injection; every two days; for 20 days; nude mice) boosts the efficacy of Sorafenib in suppressing tumor growth in a nude mouse model of HCC[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.31mL 0.46mL 0.23mL |
11.53mL 2.31mL 1.15mL |
23.07mL 4.61mL 2.31mL |
CAS号 | 667880-38-8 |
分子式 | C24H23N3O3S |
分子量 | 433.52 |
SMILES Code | O=C(C(C(N1)=O)=CC2=C(C)N(CCOC3=CC=C(C)C=C3C)C4=C2C=CC=C4)NC1=S |
MDL No. | MFCD03699567 |
别名 | |
运输 | 蓝冰 |
InChI Key | GNBZGGYWSRGVBG-UHFFFAOYSA-N |
Pubchem ID | 989566 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |